Tomkiel Melissa M.'s Form 4 filing
Strata Critical Medical, Inc. (SRTA) · filed Aug 3, 2026
- Accession no.
- 0001628280-26-051811
- Filed
- Aug 3, 2026, 4:06 PM ET
- Trade date
- Jul 30-31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tomkiel Melissa M.CIK 0001859484 | Director, Officer (Co-CEO and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Class A common stock, $0.0001 par value per share | AGrant or awardAcquired | +208,929 | $0.00 | $0 | 2,101,703 | Direct | |
| Jul 30, 2026 | Class A common stock, $0.0001 par value per share | AGrant or awardAcquired | +206,953 | $0.00 | $0 | 2,308,656 | Direct | |
| Jul 31, 2026 | Class A common stock, $0.0001 par value per share | FTax withholdingDisposed | −212,309 | $5.09 | −$1,080,652.81 | 2,096,347 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.